How does Ozempic work, explained simply

What this guide covers

Ozempic is semaglutide, a GLP-1 receptor agonist. It works by mimicking a natural gut hormone to curb appetite, slow the stomach, and steady blood sugar. Here is what that actually means, step by step. This is patient education, not a substitute for the prescriber who knows your case. Generic names sit next to brand names throughout: semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound).

Key points

• The short answer. Ozempic is the brand name for semaglutide, a once-weekly injection made by Novo Nordisk and FDA-approved for type 2 diabetes. It belongs to a class of drugs called GLP-1 receptor agonists. In plain terms, it copies a hormone your gut already makes after you eat, called GLP-1, and turns up that signal far stronger and for far longer than your own body does. That single mechanism produces three effects that matter to you: it tells your brain you are full sooner, it slows how fast your stomach empties, and it helps your pancreas release insulin at the right time. The same drug at a higher dose is sold as Wegovy for weight management; if you want that side of the story, see our Wegovy guide.
• What GLP-1 is, and why mimicking it works. GLP-1, glucagon-like peptide-1, is a hormone your intestines release when food arrives. Its natural job is to coordinate the after-meal response: nudge insulin out, quiet the hunger signal, and slow digestion so nutrients absorb steadily. The catch is that your own GLP-1 breaks down within minutes. Semaglutide is engineered to resist that breakdown, so instead of a brief pulse you get a steady, week-long signal at the same receptors. That is the whole trick. It is not a stimulant and it is not a fat-burner. It is a long-acting copy of a satiety-and-glucose hormone you already produce, which is why the appetite changes feel less like willpower and more like the hunger simply turning down.
• Effect one: appetite and the brain. The effect most people notice first is on appetite. GLP-1 receptors sit in the appetite-regulating centers of the brain, and when semaglutide activates them you feel satisfied with less food and the background 'food noise', the constant low hum of thinking about the next meal, tends to quiet down. This is the mechanism behind eating smaller portions without the white-knuckle effort of a diet. It is also why some people feel oddly disconnected from food, which can be a relief and can take some getting used to. The FDA label and the SUSTAIN trials attribute the appetite effect to this central GLP-1 action.
• Effect two: slowed gastric emptying. Semaglutide slows the rate at which your stomach passes food into your intestine, which keeps you feeling full longer after a meal. This is genuinely useful for appetite, and it is also the direct cause of most of the side effects people search for. When the stomach empties slowly, food has more time to sit and ferment, which is why nausea, sulfur burps, and reflux show up, and the slowed transit downstream is part of why constipation is so common. None of that means the drug is malfunctioning; it is the same mechanism working. Our guides on nausea, Ozempic burps, and heartburn walk through what actually helps each one.
• Effect three: insulin, glucagon, and blood sugar. This is the effect Ozempic was originally approved for. After a meal, semaglutide helps the pancreas release insulin in a glucose-dependent way, meaning it acts mainly when blood sugar is high, and it suppresses glucagon, the hormone that tells the liver to dump more sugar into the blood. The net result is steadier blood sugar and a lower HbA1c, which is why it is a type 2 diabetes drug first. Because the insulin effect is glucose-dependent, semaglutide on its own carries a low risk of hypoglycemia; that risk rises mainly when it is combined with insulin or a sulfonylurea, which is a dosing conversation for your prescriber, not a self-adjustment.

Frequently asked questions